Stratview Research has launched a new report, titled Anticancer Drug Market, By Type (Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs), Application (Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region.

Covid-19 Impact Analysis:

Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.

According to the report, The Anticancer Drug Market is projected to grow from USD 141.6 billion in 2020 to USD 215.5 billion by 2026 at a CAGR of around 7.4% during the forecast period.

Market Segments’ Analysis

By application, the anticancer drug market has been bifurcated into immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and others. The chemotherapy segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to rising healthcare expenditure, the presence of a large patient population, and early adoption of advanced drugs coupled with the presence of key market players such as Celgene Corporation (US) and Pfizer Inc. (US). The market growth in Asia-Pacific is expected to be driven by the rising number of cancer patients coupled with increasing investment in R&D activities to develop advanced cancer treatment solutions.

Key Players

The following are the key players in the Anticancer Drug market

  • F. Hoffmann-La Roche AG (Switzerland)
  • Celgene Corporation (US)
  • Pfizer Inc. (US)
  • Bristol Myers Squibb (US)
  • Novartis International AG (Switzerland)
  • AstraZeneca plc (UK)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Bayer AG (Germany)
  • GlaxoSmithKline plc (UK)

Frequently Asked Questions –

This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:

  • What is the current and future market size of Anticancer Drug market?
  • How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
  • What will be the short and long-term effects of the pandemic?
  • How are other market factors affecting the market dynamics?
  • Which segments offer high-growth opportunities in the long run?
  • How fierce is the Anticancer Drug market competition?
  • What are the key emerging trends and unmet needs in the present market?
  • What are the strategic growth opportunities and key success factors?

Read the full report:

Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to You may also connect with our market experts at  +1-313-307-4176.

About Stratview Research

Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.